These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12744625)

  • 21. Immunogenicity of Oka/Merck varicella vaccine in children vaccinated at 12-14 months of age versus 15-23 months of age.
    Silber JL; Chan IS; Wang WW; Matthews H; Kuter BJ
    Pediatr Infect Dis J; 2007 Jul; 26(7):572-6. PubMed ID: 17596796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Varicella immunity in vaccinated healthcare workers.
    Behrman A; Lopez AS; Chaves SS; Watson BM; Schmid DS
    J Clin Virol; 2013 Jun; 57(2):109-14. PubMed ID: 23434396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine.
    Gershon AA; Steinberg SP
    N Engl J Med; 1989 Apr; 320(14):892-7. PubMed ID: 2538749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase 3, open-label, Russian, multicenter, single-arm trial to evaluate the immunogenicity of varicella vaccine (VARIVAX™) in healthy adults.
    Paradis EM; Tikhonov O; Cao X; Kharit SM; Fokin A; Platt HL; Banniettis N
    Hum Vaccin Immunother; 2021 Nov; 17(11):4177-4182. PubMed ID: 34473594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
    Vesikari T; Baer M; Willems P
    Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
    Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy, safety and immunogenicity of live attenuated varicella vaccine in healthy children in China: double-blind, randomized, placebo-controlled clinical trial.
    Hao B; Chen Z; Zeng G; Huang L; Luan C; Xie Z; Chen J; Bao M; Tian X; Xu B; Wang Y; Wu J; Xia S; Yuan L; Huang J
    Clin Microbiol Infect; 2019 Aug; 25(8):1026-1031. PubMed ID: 30616012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Case of Aseptic Meningitis Without Skin Rash Caused by Oka Varicella Vaccine.
    Kawamura Y; Suzuki D; Kono T; Miura H; Kozawa K; Mizuno H; Yoshikawa T
    Pediatr Infect Dis J; 2022 Jan; 41(1):78-79. PubMed ID: 34591803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and immunogenicity of one vs. two injections of Oka/Merck varicella vaccine in healthy children.
    Ngai AL; Staehle BO; Kuter BJ; Cyanovich NM; Cho I; Matthews H; Keller P; Arvin AM; Watson B; White CJ
    Pediatr Infect Dis J; 1996 Jan; 15(1):49-54. PubMed ID: 8684876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of the Oka/GSK attenuated varicella vaccine for the prevention of chickenpox in clinical practice in Israel.
    Sheffer R; Segal D; Rahamani S; Dalal I; Linhart Y; Stein M; Shohat T; Somekh E
    Pediatr Infect Dis J; 2005 May; 24(5):434-7. PubMed ID: 15876943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experience with live attenuated varicella vaccine (Oka strain) in healthy Japanese subjects; 10-year survey at pediatric clinic.
    Ozaki T; Nishimura N; Kajita Y
    Vaccine; 2000 May; 18(22):2375-80. PubMed ID: 10738094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine.
    Watson B
    J Infect Dis; 2008 Mar; 197 Suppl 2():S143-6. PubMed ID: 18419388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Marin M; Broder KR; Temte JL; Snider DE; Seward JF;
    MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccine.
    Gillet Y; Steri GC; Behre U; Arsène JP; Lanse X; Helm K; Esposito S; Meister N; Desole MG; Douha M; Willems P
    Vaccine; 2009 Jan; 27(3):446-53. PubMed ID: 19007835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reactogenicity and immunogenicity of a live-attenuated refrigerator-stable varicella vaccine (OKA strain) in healthy seronegative subjects age 10 months to 12 years.
    Hadinegoro SR; Hindra IS; Han HH; Gatchalian S; Bock HL
    Southeast Asian J Trop Med Public Health; 2009 Sep; 40(5):991-9. PubMed ID: 19842382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
    Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
    Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity and reactogenicity of tetravalent vaccine for measles, mumps, rubella and varicella (MMRV) in healthy children: a meta-analysis of randomized controlled trials.
    Leung JH; Hirai HW; Tsoi KK
    Expert Rev Vaccines; 2015; 14(8):1149-57. PubMed ID: 26081133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety, reactogenicity, and immunogenicity of live attenuated varicella vaccine in children between 1 and 9 years of age with atopic dermatitis.
    Kreth HW; Hoeger PH;
    Eur J Pediatr; 2006 Oct; 165(10):677-83. PubMed ID: 16835758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Varicella vaccine in non-immune household contacts of children with cancer or leukaemia.
    Kappagoda C; Shaw P; Burgess M; Botham S; Cramer L
    J Paediatr Child Health; 1999 Aug; 35(4):341-5. PubMed ID: 10457288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Varicella vaccination of health-care workers.
    Burgess MA; Cossart YE; Wilkins TD; Botham S; Fearns G; Chitour K
    Vaccine; 1999 Feb; 17(7-8):765-9. PubMed ID: 10067681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.